Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE
· Real-Time Price · USD
9.77
0.86 (9.65%)
At close: Aug 15, 2025, 3:59 PM
9.80
0.36%
After-hours: Aug 15, 2025, 06:46 PM EDT
Wave Life Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 93.95M | 104.94M | 108.3M | 53.61M | 110.5M | 112.91M | 113.31M | 85.49M | 36.56M | 14.83M | 3.65M | 4.17M | 40.31M | 42.71M | 40.96M | 48.64M | 15.66M | 15.92M |
Cost of Revenue | n/a | n/a | n/a | 2.18M | 4.45M | 6.77M | 9.21M | 9.52M | 9.86M | 37.27M | 62.3M | 85.56M | 114.05M | 115.95M | 90.94M | 88.44M | 85.62M | 85.47M |
Gross Profit | 93.95M | 104.94M | 108.3M | 51.43M | 106.05M | 106.15M | 104.1M | 75.97M | 26.7M | -22.44M | -58.65M | -81.39M | -73.74M | -73.24M | -49.98M | -39.8M | -69.96M | -69.55M |
Operating Income | -143.51M | -125.75M | -110.4M | -152.05M | -83.69M | -72.17M | -68M | -92.88M | -136.22M | -154.91M | -162.72M | -155.27M | -123.97M | -121.64M | -127.02M | -121.22M | -148.03M | -146.85M |
Interest Income | 5.25M | 2.88M | 2.54M | 2.54M | 4.5M | 6.75M | 4.21M | 4.21M | 2.85M | 596K | 596K | 596K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -129.87M | -112.33M | -97.01M | -142.52M | -74.16M | -62.34M | -58.19M | -84.96M | -130.54M | -150.73M | -161.14M | -153.1M | -120.33M | -117.8M | -122.45M | -117.09M | -143.96M | -145.72M |
Net Income | -129.87M | -112.33M | -97.01M | -142.52M | -73.48M | -61.67M | -54.63M | -82.09M | -128.45M | -107.22M | -120.23M | -111.3M | -78.42M | -117.31M | -122.25M | -116.25M | -143.12M | -144.88M |
Selling & General & Admin | 67.52M | 63.83M | 59.02M | 56.55M | 54.64M | 52.61M | 51.29M | 51.35M | 49.83M | 50.37M | 50.51M | 48.9M | 50.24M | 48.4M | 46.1M | 43.71M | 40.36M | 39.59M |
Research & Development | 169.93M | 166.86M | 159.68M | 149.11M | 139.56M | 132.48M | 130.01M | 127.01M | 122.95M | 119.36M | 115.86M | 110.54M | 114.05M | 115.95M | 121.88M | 126.15M | 123.34M | 123.18M |
Other Expenses | n/a | n/a | n/a | n/a | 171K | 289K | 1.3M | 1.01M | 134K | 760K | 7K | 1.41M | 3.48M | 3.79M | 4.54M | 4.08M | 4M | 942K |
Operating Expenses | 237.46M | 230.69M | 218.71M | 205.66M | 194.19M | 185.08M | 181.3M | 178.37M | 172.78M | 169.74M | 166.37M | 159.44M | 164.29M | 164.35M | 167.98M | 169.86M | 163.69M | 162.77M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 105K | 105K | 105K | 105K | n/a | n/a | n/a | n/a | 17K | 17K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 237.46M | 230.69M | 218.71M | 205.66M | 194.19M | 185.08M | 181.3M | 178.37M | 172.78M | 169.74M | 166.37M | 159.44M | 164.29M | 164.35M | 167.98M | 169.86M | 163.69M | 162.77M |
Income Tax Expense | n/a | n/a | n/a | n/a | 677K | 677K | -2.2M | -1.52M | -2.09M | -43.51M | -40.91M | -41.8M | -41.91M | -498K | -229K | -866K | -860K | -985K |
Shares Outstanding (Basic) | 163.99M | 162.53M | 161.49M | 131.45M | 129.53M | 129.27M | 109.63M | 106.03M | 105.46M | 102.06M | 93.99M | 92.87M | 66.48M | 60.52M | 57.01M | 50.71M | 49.97M | 49.1M |
Shares Outstanding (Diluted) | 163.99M | 162.53M | 172.29M | 132.56M | 129.53M | 129.27M | 109.63M | 106.98M | 105.46M | 102.06M | 93.99M | 93.9M | 66.48M | 60.52M | 57.19M | 50.71M | 49.97M | 49.1M |
EPS (Basic) | -0.89 | -0.83 | -0.78 | -1.11 | -0.57 | -0.52 | -0.52 | -0.84 | -1.33 | -1.13 | -1.51 | -1.65 | -1.35 | -2.13 | -2.37 | -2.35 | -3.09 | -3.46 |
EPS (Diluted) | -0.9 | -0.84 | -0.79 | -1.11 | -0.57 | -0.52 | -0.52 | -0.84 | -1.33 | -1.13 | -1.51 | -1.65 | -1.35 | -2.13 | -2.37 | -2.35 | -3.09 | -3.46 |
EBITDA | -134.84M | -117.1M | -101.74M | -143.36M | -74.9M | -63.22M | -58.79M | -82.82M | -125.93M | -143.57M | -151.03M | -142.95M | -111.75M | -109.29M | -113.99M | -108.66M | -135.35M | -135.66M |
EBIT | -143.51M | -125.75M | -110.4M | -152.05M | -83.69M | -72.17M | -68M | -92.88M | -136.22M | -154.91M | -162.72M | -155.27M | -123.97M | -121.64M | -127.02M | -121.22M | -148.03M | -146.85M |
Depreciation & Amortization | 8.67M | 8.65M | 8.66M | 8.69M | 8.79M | 8.95M | 9.21M | 9.52M | 9.86M | 10.04M | 10.11M | 10.16M | 9.95M | 9.89M | 9.84M | 9.81M | 9.92M | 9.96M |